• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.16% Nasdaq Down0.08%

    Alnylam Pharmaceuticals, Inc. (ALNY)

    -NMS
    117.84 Up 0.27(0.23%) 4:00PM EDT
    |After Hours : 117.84 0.00 (0.00%) 4:14PM EDT
    Add to Portfolio
    Cash FlowGet Cash Flow for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
    Net Income (360,395) (89,225) (106,014)
    Operating Activities, Cash Flows Provided By or Used In
    Depreciation11,926  10,229  9,035  
    Adjustments To Net Income212,229  18,457  (9,665)
    Changes In Accounts Receivables(35,689)(4,144)1,364  
    Changes In Liabilities10,176  (2,822)(13,889)
    Changes In Inventories -   -   -  
    Changes In Other Operating Activities(3,888)(1,152)3,560  
    Total Cash Flow From Operating Activities (165,641) (68,657) (115,609)
    Investing Activities, Cash Flows Provided By or Used In
    Capital Expenditures(8,961)(4,006)(8,348)
    Investments(514,853)(126,499)11,884  
    Other Cash flows from Investing Activities(25,000) -  (162)
    Total Cash Flows From Investing Activities (548,814) (130,505) 3,374  
    Financing Activities, Cash Flows Provided By or Used In
    Dividends Paid -   -   -  
    Sale Purchase of Stock736,465  200,926  93,412  
    Net Borrowings -   -   -  
    Other Cash Flows from Financing Activities -   -   -  
    Total Cash Flows From Financing Activities 736,465   200,926   93,412  
    Effect Of Exchange Rate Changes -   -   -  
    Change In Cash and Cash Equivalents 22,010   1,764   (18,823)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.